D
Arcus Biosciences, Inc. RCUS
$9.34 -$0.20-2.10%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -16.13% 50.00% 34.48% 480.00% -8.82%
Total Other Revenue -- -- -- -- --
Total Revenue -16.13% 50.00% 34.48% 480.00% -8.82%
Cost of Revenue 8.60% 50.00% 11.11% 34.57% 16.25%
Gross Profit -20.97% -50.00% 45.00% 164.29% -34.78%
SG&A Expenses -3.45% 0.00% 7.14% 6.67% 3.57%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 5.74% 36.61% 29.46% 27.03% 12.96%
Operating Income -13.19% -31.25% -27.71% 104.65% -22.97%
Income Before Tax -16.25% -33.33% -25.68% 94.87% -19.40%
Income Tax Expenses 0.00% -- -- -- --
Earnings from Continuing Operations -16.05% -29.58% -24.00% 95.00% -20.90%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -16.05% -29.58% -24.00% 95.00% -20.90%
EBIT -13.19% -31.25% -27.71% 104.65% -22.97%
EBITDA -13.64% -30.38% -28.40% 108.33% -20.55%
EPS Basic 5.08% -5.77% 0.36% 95.77% -17.02%
Normalized Basic EPS 4.92% -8.82% -0.98% 117.37% -15.59%
EPS Diluted 5.08% -5.77% 0.36% 95.77% -16.82%
Normalized Diluted EPS 4.92% -8.82% -0.98% 117.37% -15.59%
Average Basic Shares Outstanding 22.27% 22.52% 24.45% 18.08% 3.31%
Average Diluted Shares Outstanding 22.27% 22.52% 24.45% 18.08% 3.31%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings